# PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)

> **NCT05269550** · NA · ACTIVE_NOT_RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 50 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** High-Intermediate Risk Patients-cohort 1
- **RADIATION:** High Risk or Very High-Risk Patients-cohort 1
- **RADIATION:** High-Intermediate Risk Patients-cohort 2
- **RADIATION:** High Risk or Very High-Risk Patients-cohort 2

## Key facts

- **NCT ID:** NCT05269550
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-03
- **Primary completion:** 2028-12-15
- **Final completion:** 2028-12-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05269550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05269550, "PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05269550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*